Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01GQD
|
||||
| Former ID |
DCL001183
|
||||
| Drug Name |
EZN-3042
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [551623] | ||
| Company |
Santaris Pharma A/S
|
||||
| Target and Pathway | |||||
| Target(s) | Baculoviral IAP repeat-containing protein 5 | Target Info | Modulator | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| Pathway Interaction Database | Aurora B signaling | ||||
| Validated targets of C-MYC transcriptional activation | |||||
| FOXM1 transcription factor network | |||||
| Aurora A signaling | |||||
| References | |||||